3 firms get clinical trial approval for alternative Covid-19 drugs

The drug 2-DG is not yet an approved drug, but there have been multiple studies across the globe for treatment of cancers

Topics
Coronavirus Vaccine | Pharma Companies

Sohini Das  |  Mumbai 

Domestic players are working on multiple off-label therapies that may be useful for treating Covid-19. The drug regulator is evaluating several of these proposals that have come from firms such as Dr Reddy’s Laboratories (DRL), Piramal Pharma, and Cadila Healthcare, among others.

Hyderabad-based DRL, for example, has been asked to conduct phase-3 clinical trial of a potential cancer drug (2-Deoxy-d-Glucose oral power, or 2-DG) to see if it works as a therapy for Covid-19 patients. The drug 2-DG stops glucose supply to the cells, which then start dying. It is a potential ...

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Fri, October 16 2020. 06:05 IST
RECOMMENDED FOR YOU
.